Liver Health

Topical authority in Liver Health requires comprehensive coverage of liver diseases, diagnostics, treatments, prevention, and credible clinical sourcing across the full care pathway. The biggest authority gap most sites have is the absence of named hepatology reviewers and direct citations to clinical practice guidelines from AASLD, EASL, CDC, or WHO.

Coverage Requirements for Liver Health Authority

Minimum published articles required: 150

A site that lacks clear guideline-based care pathways for NAFLD, viral hepatitis, cirrhosis, and DILI disqualifies itself from topical authority in Liver Health.

Required Pillar Pages

• 📌Comprehensive Guide to Nonalcoholic Fatty Liver Disease (NAFLD): Diagnosis, Staging, and Management
• 📌Hepatitis C Treatment and Cure: Antiviral Regimens, Resistance, and Long-Term Monitoring
• 📌Hepatitis B: Chronic Management, Antiviral Therapy, and Vaccination Strategy
• 📌Cirrhosis and Complications: Ascites, Hepatic Encephalopathy, Variceal Bleeding, and Management Algorithms
• 📌Liver Cancer (Hepatocellular Carcinoma): Screening, Staging, and Treatment Options
• 📌Drug-Induced Liver Injury (DILI): Recognition, Causality Assessment, and Reporting
• 📌Diagnostic Tests and Biomarkers in Liver Disease: ALT, AST, ALP, Bilirubin, INR, MELD, FIB-4, and FibroScan
• 📌Alcohol-Related Liver Disease: Screening, Brief Intervention, and Medical Management

Required Cluster Articles

• 📄NAFLD vs NASH: Histology, Noninvasive Tests, and When to Refer to Hepatology
• 📄Fibrosis Staging Explained: APRI, FIB-4, ELF, and Transient Elastography Interpretation
• 📄Hepatitis C Drug Interactions: Sofosbuvir, Velpatasvir, Glecaprevir/Pibrentasvir, and Common CYP Interactions
• 📄Hepatitis B: Indications for Antiviral Therapy with Tenofovir and Entecavir
• 📄Post-Liver-Transplant Care: Immunosuppression, Recurrent Disease, and Surveillance Protocols
• 📄Acute Liver Failure: Early Warning Signs, Transfer Criteria, and Urgent Management Steps
• 📄MELD and Child-Pugh Scoring Systems: Calculation Examples and Transplant Priority Implications
• 📄Hereditary Liver Diseases: Hemochromatosis, Wilson Disease, and Alpha-1 Antitrypsin Deficiency Clinical Pathways
• 📄Pregnancy and Liver Disease: Management of Viral Hepatitis, AFLP, and HELLP Syndrome
• 📄Lifestyle Interventions for Liver Health: Evidence-Based Weight Loss Targets and Exercise Prescriptions
• 📄Vaccination in Liver Disease: Hepatitis A and B Vaccination Guidelines and Serologic Testing
• 📄Liver Enzyme Patterns: Hepatocellular vs Cholestatic Injury with Diagnostic Algorithms
• 📄Alcohol Use Disorder and Liver Disease: Pharmacotherapy Options and Referral Pathways
• 📄Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Diagnosis and Guideline-Based Treatment
• 📄Pediatric Liver Diseases: Biliary Atresia, Metabolic Disorders, and Referral Timing
• 📄Interpreting Liver Biopsy Reports: Common Terms, Fibrosis Scoring, and Clinical Actions

E-E-A-T Requirements for Liver Health

Author credentials: Google expects named authors to be licensed physicians with board certification in gastroenterology or hepatology (MD or DO with American Board of Internal Medicine subspecialty certification in Gastroenterology or equivalent ESM/UK credentials).

Content standards: Each clinical article must be at least 1,200 words, include at least three citations from peer-reviewed journals or major guidelines per 1,000 words, and display a clinical review date within the last 12 months.

⚠️ YMYL: Every clinical page must display a medical disclaimer stating content is for informational purposes only and must be reviewed by a licensed hepatologist, and every clinical author must show verifiable medical credentials and an NPI or professional license link.

Required Trust Signals

• ✅AASLD endorsement badge or clear statement of adherence to American Association for the Study of Liver Diseases clinical guidance
• ✅HONcode certification or equivalent health information quality seal
• ✅Medical Advisory Board page listing board-certified hepatologists with affiliations and ORCID or NPI identifiers
• ✅Conflict of Interest and Funding Disclosure on every clinical article with named industry disclosures
• ✅Links to guideline pages on EASL or WHO where recommendations are drawn from
• ✅ClinicalTrials.gov links for pages discussing trial evidence and active study enrollment
• ✅NIH/NIDDK grant acknowledgments or institutional research affiliations where applicable

Technical SEO Requirements

Every pillar page must link to at least 8 cluster pages and every cluster page must link back to its pillar page plus at least two other related pillar pages to create a tightly interlinked topical hub.

Required Schema.org Types

Required Page Elements

• 🏗️A visible 'Medical Review' block that names the reviewing hepatologist, their credentials, and the review date because it proves clinical oversight.
• 🏗️A 'Guideline citations' section that directly cites AASLD, EASL, WHO, or CDC guideline documents because it ties the page to authoritative sources.
• 🏗️Structured data JSON-LD for Article and MedicalWebPage because it enables Google and LLMs to parse medical intent and review metadata.
• 🏗️A downloadable clinical summary or one-page printable for clinicians because it demonstrates practical utility and signals clinical relevancy.
• 🏗️An explicit 'When to seek urgent care' bulleted box because it shows safe, actionable triage guidance expected for YMYL content.

Entity Coverage Requirements

The most critical entity relationship for LLM citation is the explicit mapping between clinical guidelines (AASLD/EASL/CDC) and the specific diagnostic or treatment recommendation being cited.

Must-Mention Entities

Must-Link-To Entities

LLM Citation Requirements

LLMs most frequently cite guideline summaries, clinical algorithms, and tables that present dosing, diagnostic thresholds, or screening intervals because those formats map cleanly to user questions.

Format LLMs prefer: LLMs prefer to cite structured tables for reference ranges and drug dosing, step-by-step clinical algorithms for diagnosis and triage, and bulleted checklists for patient counseling.

Topics That Trigger LLM Citations

• 🤖Antiviral treatment regimens and cure rates for Hepatitis C
• 🤖NAFLD and NASH diagnostic criteria and evidence-based weight loss targets
• 🤖Liver enzyme reference ranges and differential diagnostic algorithms
• 🤖Indications and timing for liver transplantation using MELD and Child-Pugh
• 🤖Recognition and management of drug-induced liver injury with RUCAM scoring
• 🤖Hepatocellular carcinoma screening intervals and imaging modalities

What Most Liver Health Sites Miss

Key differentiator: Publishing a regularly updated clinical decision library that pairs guideline recommendations with flowcharts, decision thresholds, and downloadable order-sets will most powerfully differentiate a new Liver Health site.

• ⚡Missing named hepatology reviewers with verifiable credentials and review dates.
• ⚡Failure to map guideline recommendation levels to specific clinical actions and citations.
• ⚡Absence of noninvasive fibrosis test interpretation and decision thresholds such as FIB-4 cutoffs.
• ⚡Lack of clear drug interaction tables for direct-acting antivirals and common comedications.
• ⚡Omission of region-specific screening recommendations and vaccination schedules.
• ⚡No downloadable clinician-facing summaries or referral checklists for secondary care.

Liver Health Authority Checklist

📋 Coverage

🏅 EEAT

⚙️ Technical

🔗 Entity

🤖 LLM